Background--The American College of Cardiology and American Heart Association periodically revise clinical practice guidelines. We evaluated changes in the evidence underlying guidelines published over a 10-year period.
C linical practice guidelines provide a vetted framework for high-quality, up-to-date standards of care to guide clinicians in important management decisions. National professional organizations make these recommendations through committee consensus after systematic review of scientific evidence, 1 while using caution to minimize conflict of interest and ensure that the guidelines are relevant to clinical practice. 2 To keep pace with evolving practice standards and evidence, new guidelines are created while older guidelines are periodically revised.
Since 1984, the American College of Cardiology (ACC) and American Heart Association (AHA) have concurrently produced recommendations for clinicians who care for patients with, or who are at risk for, cardiovascular disease. 3 The strength and relative benefit-to-risk ratio of each recommendation is expressed as the class of recommendation (COR), while the quality of the underlying evidence is expressed by the level of evidence (LOE) designation (Table 1) . [4] [5] [6] Fullguideline revisions occur approximately every 4 or more years, but individual recommendations may be reviewed annually. 7 Individual recommendation revisions are termed "focused updates," as they represent the most current amendments, deletions, or additions to guidelines based on significant new research.
It is important to understand how the guidelines evolve in order to keep pace with advances in clinical practice. An important, previous study demonstrated that only a median of 11% of ACC/AHA recommendations before 2009 were based on LOE A and nearly half relied on LOE C. 5 Additionally, this same article determined that only 19% of recommendations were of class I with LOE A. However, little is known about how the guidelines have evolved over the past decade. There was only 1 study looking at the change in guidelines over the past decade, but this previous study only focused on atrial fibrillation. 8 Our study examined all cardiology topic areas of ACC/AHA clinical practice guidelines published in the past decade, stratified by 6 topic areas ( [1] arrhythmias; [2] prevention; [3] acute and stable ischemia; [4] heart failure; [5] valvular heart disease; and [6] vascular medicine) to assess changes in the number of recommendations as well as the distribution of recommendations across LOE and COR over time ( Table 2 ). Methods
Data Source and Sample
The data that support the findings of this study are available from the corresponding author upon reasonable request.
ACC/AHA clinical practice guidelines and focused updates published between 2008 and 2017 were separated into 2 time periods, 2008 to 2012 and 2013 to 2017, as the last comprehensive analysis of ACC/AHA recommendations was accomplished in 2008. 5 Guidelines during these 2 periods were determined by those listed on the ACC "guideline and clinical documents" webpage (http:// www.acc.org/guidelines) and PubMed MEDLINE database search terms of "ACC/AHA guideline" or "ACCF/AHA." 52 Guidelines were categorized into the following cardiology topic areas: (1) arrhythmias, (2) prevention, (3) acute and stable ischemia, (4) heart failure, (5) valvular heart disease, and (6) vascular medicine to loosely represent cardiology subspecialties. Focused updates were included, as they represent the most current amendments, deletions, or additions to guidelines based on significant research or clinical findings, similarly to a recent study. 8 If a focused update was included with an earlier full guideline in that time period, the full guideline recommendation associated with that focused update was revised accordingly and not counted twice. "Extracranial Carotid and Vertebral Artery Disease" 53 and "Thoracic Artery Disease" 54 were excluded because they have not been updated since their 2011 and 2010 versions, respectively, and thus would not have a counterpart for comparison.
Main Outcome Measures
The total number of recommendations, designated COR, and LOE for each individual recommendation, were abstracted. Definitions of each COR and LOE class can be found in Figure 1 . Class IIa and IIb were categorized into Class II for our evaluation. It should be noted that IIa recommendations are considered "reasonable" in terms of expected benefit versus risk for a patient (Table 1 ). In comparison, COR IIb recommendations are considered "may/might be reasonable." 1, 5, 6 Next, each combined COR-LOE class (ie, I-A, I-B, etc) was collected per recommendation for each time period (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) to compare which specific recommendation class occurred most frequently, and if changes over time existed. All data were collected via 1 abstracter during a consecutive 2-month period and stored into Microsoft Excel work pages.
Statistical Analysis
In each cardiology topic area, the proportion of recommendations in each COR category and each LOE category was calculated. Percentage differences in the number of recommendations, COR, and LOE across the 2 study periods (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) for each topic area were determined. Correlation coefficients were determined between class of recommendation and level of evidence via Microsoft Excel for the 2 time periods.
Clinical Perspective
What Is New?
• Over the past decade, there has been a decrease in the total number of recommendations in the American College of Cardiology/American Heart Association guidelines, driven by removal of recommendations based on lower quality of evidence (Level C evidence), although there has not been a corresponding increase in the highest quality of evidence (Level A evidence). • Over the past 10 years, American College of Cardiology/ American Heart Association clinical practice guidelines have been significantly streamlined and increasingly emphasize high-quality evidence and de-emphasize expert opinion and other lower levels of evidence.
What Are the Clinical Implications?
• This focus on condensing recommendations has the potential to increase the clinical utility of guidelines for practicing clinicians.
Results
Overall, 35 guidelines were included in this study; 16 were published from 2008 to 2012 and 19 were published from 2013 to 2017. The guidelines comprised 4711 total recommendations, including 2713 from 2008 to 2012 and 1998 from 2013 to 2017 (Table 3 ). The median number of recommendations per each of the 6 topic areas was 281 (interquartile range 198-536) in 2008-2012 versus 247 (interquartile range 190-451) in [2013] [2014] [2015] [2016] [2017] . The greatest proportional decrease in the number of recommendations was in the acute and stable ischemia, arrhythmia, and valvular heart disease topic areas, with a reduction of 44% (decrease of 535), 15% (decrease of 91), and 25% (decrease in 80) recommendations, respectively. There were roughly the same number of full guidelines in almost every topic area when comparing the 2008 to 2012 group to the 2013 to 2017 group ( Table 2 ). The only topic area to incur an increase in number of full guidelines was "prevention," with an increase of 39% (increase of 71 recommendations). This topic area also had an increase in number of guidelines from 4 full guidelines in the 2008 to 2012 group to 6 full guidelines in the 2013 to 2017 group. Of the 6 topic areas, the median proportion for COR I from 2008 to 2012 recommendations was 49.3%, while for 2013 to 2017 the median proportion was 44.4% ( Figure 2 ). COR II demonstrated median proportions of 38.0% and 44.5% for the time periods 2008 to 2012 and 2013 to 2017, respectively. Lastly, the median proportion for COR III from 2008 to 2012 recommendations was 12.5%, and the median proportion for 2013 to 2017 was 11.2%. Figure 4 ). An increase in the proportion of LOE B recommendations was observed for these same areas: 31.8%, 19.2%, and 23.8% for heart failure, valvular heart disease, and arrhythmias, respectively. Level of evidence (LOE) indicates the quantity and type of scientific evidence supporting a recommendation. The scientific evidence can consist of randomized controlled trials (RCT), meta-analyses, observational studies, etc. Definitions, as stated by American College of Cardiology/American Heart Association, are above. 1, [4] [5] [6] As stated by the 2015 American College of Cardiology/American Heart Association recommendations, levels B and C have been separated into B-R (randomized), B-NR (nonrandomized), C-LD (limited data), and C-EO (expert opinion). However, to stay consistent with past data, recommendations that fell into these categories were defined as levels B and C in this study. 7 Class of recommendation (COR) suggests the strength of a recommendation and thereby indicates the expected benefit vs risk for a patient. There are 2 determinant factors in designating a COR score. The first is a judgment based on strengths and weaknesses of scientific evidence on the matter. The second determinant is a judgment by a panel of experts in cardiology on the general agreement regarding efficacy and usefulness for patients. Definitions, as stated by American College of Cardiology/American Heart Association, are above. 1, [4] [5] [6] As stated by the 2015 American College of Cardiology/American Heart Association recommendations, class III is separated into "no benefit" and "harm"; however, to stay consistent with past data, class III was defined as 1 category in this study. (2014) Perioperative evaluation (2007) Cardiovascular risk (2013) Cardiovascular risk for asymptomatic patients (2010) Blood cholesterol (2013) Overweight/obese (2013) Lifestyle management (2013) Acute 
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Secondary Analysis
A secondary analysis was conducted to analyze the results in terms of guidelines that were published during both periods ( Tables 4 and 5 ). There was a decrease in total recommendations across all topic areas. The largest decrease in total recommendations was found in "acute and stable ischemia" (decrease of 422 recommendations) as similar to when all guidelines were included in the analysis. Guidelines CABG 2011 and DAPT 2016 were not included in this analysis as compared with when all guidelines were included. Trends continued to be similar as to when all guidelines were included (Table 5 ).
Discussion
There has been a reduction in the number of recommendations in the ACC/AHA clinical practice guidelines published in Many useful and beneficial cardiology clinical practice guidelines exist, but with growing knowledge and research, constantly adding new recommendations to the already existing list could make it difficult for care providers to utilize all of the recommendations. 1 Thus, efforts to streamline recommendations could be very beneficial for clinicians. The largest reduction in number of recommendations occurred in the ST-Segment-Elevation Myocardial Infarction guideline (a reduction of more than two thirds). Overall, the topics covered in the updated guideline are very similar to those found in the initial guideline. However, there is a reduction in the number of recommendations listed in the updated version, suggesting that multiple recommendations were condensed into more parsimonious recommendations. The most recent guideline also acknowledged an "attempt to provide a more focused tool for practioners, 55 " indicating their expressed goal to condense information for ease of use.
Recommendations based on the weakest evidence were disproportionally removed. This was most apparent in the "heart failure," "acute and stable ischemia," and "valvular heart disease" guidelines, which each had an 50% reduction in LOE C recommendations. Condensing extensive documents to include a greater proportion of stronger recommendation underpinned by higher-quality evidence focuses the messages to practicing clinicians. However, LOE A recommendations remain fairly uncommon. This is likely because, although more randomized controlled trials have been published, these trials may not have the necessary size or rigor to produce increased LOE A recommendations. It is possible that some LOE C recommendations were upgraded to LOE B as more published data become available over time. However, it is also possible that certain eliminated recommendations were relocated to ACC/AHA Expert Consensus Documents, also referred to as Expert Consensus Decision Pathways or AHA Scientific Statements. These documents provide guidance on making clinical decisions, especially on topics that have limited data or are new and thus research has not been completed on the topic. 2 Use of expert consensus documents and/or decision pathways may be more appropriate for topics where expert opinion is important but high-quality evidence is not yet available. Thus, if the committee felt that a recommendation did not consist of high-quality evidence, the recommendation may have been removed from a guideline and placed in an Expert Consensus Document to still allow communication of accepted best practices to the cardiology community.
There was a decrease in proportion of COR I and COR III recommendations and an increase in proportion of COR II recommendations over time. Since these classifications are determined by a panel of experts based on benefit-to-risk ratio, if not enough data are available to determine if a recommendation is fully beneficial or not beneficial, a recommendation is designated as COR II (may or may not be beneficial). 7 We speculate that the increase in COR II recommendations over time indicates maintenance of a rigorous consensus process by the panel of experts to classify each recommendation in the context of an increasingly complex and, at times, conflicting body of literature.
We note that a limitation of the current study is that, while we examined the total number of recommendations by LOE and COR, we did not map individual recommendations over time to assess how each might have been combined, eliminated, or changed over the study period. Additionally, some guidelines differed between the 2 time periods, which limits our ability to make direct comparisons between the 2 time periods.
Conclusion
Over the past 10 years, ACC/AHA clinical practice guidelines have been significantly streamlined and increasingly emphasize high-quality evidence and de-emphasize expert opinion and other lower levels of evidence. This focus on condensing recommendations has the potential to increase the clinical utility of guidelines for practicing clinicians. Each topic area consists of various American College of Cardiology/American Heart Association Cardiology Guidelines. 9 
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